News Zhejiang Xianju Pharmaceutical Co.,Ltd.

Equities

002332

CNE100000K64

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
12.16 ^CNY	-0.82%		-1.94%	-4.78%

Apr. 24	Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2023	Xianju Pharma to Invest 33 Million Yuan in Local Drug R&D Firm	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Zhejiang Xianju Pharmaceutical Co.,Ltd. Announces 2023 Final Profit Distribution on A Shares, Payable on 05 June 2024	May. 30	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Approves Cash Dividend for the Year 2023	May. 21	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Proposes Final Dividend for the Year 2023	Apr. 24	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 24	CI
Xianju Pharma to Invest 33 Million Yuan in Local Drug R&D Firm	Dec. 27	MT
Hangzhou Yuhong Pharmaceutical Technology Co., Ltd. announced that it expects to receive CNY 80 million in funding from Zhejiang Xianju Pharmaceutical Co.,Ltd., Jiaxing Miyin Yuhong Equity Investment Partnership Enterprise (L.P.), Hainan Huishengde Enterprise Management Partnership Enterprise (L.P.), Hangzhou Yulin Enterprise Management Partnership Enterprise (L.P.)	Dec. 25	CI
Zhejiang Xianju Pharmaceutical's Flumazenil Injection Chosen for China's Centralized Bid	Nov. 08	MT
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-23	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 02 June 2023	23-05-29	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Approves Cash Dividend for the Year 2022	23-05-24	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Proposes Final Dividend for 2022	23-04-26	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Zhejiang Xianju Pharma’s Abortion Tablet Passes Consistency Evaluation	23-03-10	MT
Zhejiang Xianju Pharma Logs 20.4% Jump in 2022 Profit	23-02-24	MT
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-23	CI
Ningbo Linghan Enterprise Management Partnership Enterprise (Limited Partnership) entered into equity transaction contract to acquire 14.60% stake in Hangzhou Weisibo Medical Technology Co., Ltd. from Zhejiang Xianju Pharmaceutical Co.,Ltd. for CNY 8 million.	22-12-28	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Approves Management Elections	22-12-26	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd.(SZSE:002332) dropped from Shenzhen Stock Exchange Component A Share Index	22-12-09	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd.(SZSE:002332) dropped from Shenzhen Stock Exchange Component Index	22-12-09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Zhejiang Xianju Pharmaceutical Co.,Ltd.

Equities

002332

CNE100000K64

Summary

Filters